Block Admission Return

Hutchison China Meditech Limited
27 December 2007





                  Hutchison China MediTech Limited ('Chi-Med')

                                   (AIM: HCM)


Block Admission Return





London, Thursday, 27 December 2007: Chi-Med announces the following block
admission return:


Name of the company:                                     Hutchison China MediTech Limited


Name of the scheme:                                      Hutchison China MediTech Limited Share Option
                                                         Scheme


Period of return:                                        From 26 June 2007 to 26 December 2007


Number and class of securities not issued under the      2,560,606 ordinary shares of US$1 each
scheme at the beginning of the period:


Number of securities issued under the scheme during      17,053 ordinary shares of US$1 each
the period:

Balance under the scheme of securities not yet           2,543,553 ordinary shares of US$1 each
issued at the end of the period:


Number and class of securities originally admitted       2,560,606 ordinary shares of US$1 each admitted
and the date of admission:                               on 26 June 2007


The total number of securities in issue at the end of the period was 51,229,174 ordinary shares of US$1
each.



                                      Ends





Enquiries


Chi-Med                                                Telephone: [phone]

Christian Hogg, CEO


Citigate Dewe Rogerson                                 Telephone: [phone]



Anthony Carlisle                                       Mobile: [phone]

Yvonne Alexander                                       Mobile: [phone]




About Chi-Med



Chi-Med is the holding company of a pharmaceutical and healthcare group based
primarily in China and was admitted to trading on the Alternative Investment
Market of the London Stock Exchange in May 2006. Chi-Med focuses on research,
development, manufacture and sale of pharmaceuticals, health supplements and
other consumer health and personal care products derived from Traditional
Chinese Medicine and botanical ingredients.



Chi-Med is majority owned by Hutchison Whampoa Limited, an international
corporation listed on the Main Board of The Stock Exchange of Hong Kong Limited.


                      This information is provided by RNS
            The company news service from the London Stock Exchange